41 Drugs to Die For

24 10 2010
Prescription Drugs “Can” be a Bit Like Rolling the Dice in Vegas

    I’ve stated before, “Anything manmade and outside of God’s natural organic order, can/will cause ill-health medical conditions.”  And there is nothing more true to this statement and applicable relative to the plethora of FDA approved drugs that are causing great harm to those with medical conditions and dependent on pharmaceuticals.

     Although I believe there is no manmade drug (including long-storage processed/restaurant, fast-foods) that is entirely good for us, I would concede there are medical conditions where specific types of drugs given to patients far outweigh the health risk consequences than going without.

     My biggest concern with our FDA (Federal Drug Administration) approved drugs process is the sheer number of products coming to market.  Recall, before these drugs come to market there is an extensive FDA safety-approval process that also equates to billions of R&D (Research & Development) dollars where investors demand a ROI (Return on Investment) by bringing product to market.  And it is also true that that much of the FDA’s budget is greatly dependent upon the pharmaceutical products and services industries.  These industry resources also equate to 10’s of thousands of government, private sector and special interest jobs, within our health care industry.

     It is my opinion, the drug companies know full well how to fudge research data and the FDA knows how to give a free pass.  Folks this is a dangerous combination for the unknowing patient in need of safe effective drugs with minimal side effects.  We already know anything manmade is going to create additional risk for our health.  However, how much unnecessary risk should the “unknowing” patient take?  Are drugs that create high risk health conditions with “little-to-no” health benefits really necessary?  And has our drug approval process “now” incorporated increased health risk conditions and acceptable death rate into the cost-of-doing business?  And is litigation and class action lawsuits now factored into the cost of doing business as well?

     It would appear, “patients” have become a part of the “rat” lab program included into the cost or R&D “in our open markets!” Human studies now are disguised through a “free pass to market” process that incorporates reuse of the same drug(s); “pulled from consumer use,” and then relabeled  under different names (read below “Off-Market Labels”) to treat conditions that were not initially approved by the FDA.  I submit… The cost of doing business in expediting drug-to-market approval for use on humans is more cost effective with better correlated data than animal lab studies.

     It seems the paradigm shift is “now” Humans are an expendable commodity where the cost of doing business is settled through class action lawsuits to appease suffering families by compensating financially.  Also more research animals are saved, simultaneously keeping activist at bay; investors also make huge fortunes; government and private sector jobs and special interests continue to thrive and grow.

     Have we become the little white rats supporting the Off-Market Label drug trials as drug products are expedited for use in the marketplace?  And is this why our prescription drugs have a ridiculously high cost:  “Factor cost of class action lawsuits; off-label product marketing costs and FDA blind-eye policy and underwriter kickbacks to give a green light on a free pass to market.”  Are Off-Market Label drug policies breaking our healthcare systems back?  Is there anything that can be done about it?

     American greed knows no boundaries.  Those without a moral compass care only about their here and now.  Think about it.  I don’t know the entire solution in how to resolve this particular crux.  My only thought is, without moral leadership at the helm of any private, corporate, or government regulatory agency, these types of things will change little because of a corrupt soul.

     What can we the consumer do about this.  We the people “do” have the power to change consumer regulatory control.  “Vote the vermin out of government office and fill the seats with good guys.”  How do you know who the good guys are?  Simple, they have an undeniable morale leadership character and honorable past with little interest in lining their pockets (look for the money trail which is a dead giveaway).  Also, look for agenda motive and who endorses them.  Good guys also don’t seek recognition for doing the right things, it just comes to them.  And they only seek to rise higher in the leadership hierarchy to do greater good serving the people and appointing “moral good guys/gals.”  They are also responsible and accountable for their actions and to the people under which they serve.

     I’ve listed 5 of the 41 most dangerous class action lawsuit prescription drugs below.  All of these drugs have caused serious health problems for patients and even death.  The lawsuits are an indicator that even with inception of new drug products to market; this “quick product to market” approach is not going to stop anytime soon.  It has only gotten more complicated with Off-Market Labels and class action lawsuits.  As long as the FDA continues to turn a blind eye to R&D data, and class action lawsuits data statistics, etc.  Consumers will continue to experience more ill-health side effects and prescription induced “early” death through the off-label drug to market process.

     Even the fines issued by the FDA are only a slap on the wrist to hundreds of billion dollar companies.  Fines do not incentivize these companies to change the way they do business, but instead provides a “pay-per-play” drug policy which gives the appearance of our Federal government doing something about malicious business practices.  If our government really cared, they’d slap an injunction to stop distribution-to-market and remove any drug label that is deemed to have caused significant medical harm and death.  And if they were serious about consumer protection, fine these companies in a way that hurts their bottom line and require these companies to begin the R&D approval process over from start to finish.   But this won’t happen, why?  Federal regulatory agencies are in bed with these deep pocketed special interest companies and addicted to the money.

     However, it is now obvious the FDA drug approval process trust is being challenged by many consumer class action lawsuits with no end in sight.  The FDA is under a tremendous amount of pressure from the government oversight committees, consumer watch dogs and other advocates against the current drug-to-market protocols that is releasing bad drugs into the market.  If this “business as usual” approach does not change, further erosion of Obama care mandates will occur because policy will prove to be “cost unsustainable.”  And if health reform does not control the “status quo” drug approval process, these governmental policies will crumble and take our economy with it.  As to continue forward with such drug approval processes will cause irreversible harm to our health care services and economy.

 Five out of 41 Most Dangerous Drugs in Class Action Lawsuits.  See following Link: http://www.legallawhelp.com/safety_and_health/defective_drugs.html

 “Accutane:   Lawsuit 2010-09-30 – This was an approved FDA, “award winning” vitamin A derivative to treat various forms of cancer highly effective at mitigating and killing the spread of cells in the pancreas, brain and nevoid basal cell carcinoma syndrome.  There are now many problematic side-effect and deaths as a result of use.  Some of the serious side-effects include but not limited to:  Bowl disease, psychosis, hepatitis, pancreatic, myalgia, raised blood glucose, etc., And birth defect rates are extremely high when proper screening before prescription occurred.   Legal action is the result of either party(s) wrongly prescribed, or misunderstood use of, or detailed information of potential risks/brochures, or a signed consent form of understanding of pharmacist was not accomplished per prudent protocols.”  http://accutanelawsuit2010.net/

 “Vioxx and Bextra:  Approved by the FDA – A new study links certain painkillers to High Cholesterol, 13 Feb 2007.  Pain killers known as COX-2 inhibitors (Vioxx and Bextra) at the time of the study were shown to increase excess cholesterol for lack of purging it from the body.  This increased the possibilities of blood clot and stroke.  Lipid loads in the body when using this anti-arthritic pain alleviation drugs were shown to increase leading to cardiovascular issues with pain patients.”  http://vioxx.pharmaceutical-lawsuits.com/

 “Ketek:  An anti-biotic was linked to liver failure and other problems.  Originally Ketek was approved by the FDA to treat sinusitis and bronchitis.  Because of the problems it was no longer allowed for use by the FDA as originally intended.  However, in 2004 was approved to treat pneumonia outside of a hospital or nursing home.  The statements made by former physician David Ross who worked on pre-approval for FDA at Center for Drug Evaluation and Research (CDER) after 10 years stated “his superiors forced him to soften his unflattering review of the drugs.” http://www.newsinferno.com/legal-news/ketek-lawsuit-filed-in-illinois-says-sanofi-aventis-knew-of-liver-failure-side-effects/

 “Zyprexa:  Approved in 1996 and has been used for years to treat schizophrenia and bipolar disorder.  Clinical trials have shown this drug to cause weight gain and diabetes.  The CDER is known by prominent medical clinical research professional(s) regards the pharmaceutical industry as the FDA’s(agency) main client.  Off-label marketing (specific falsities as to the side effects of a drug) for anti-psychotic drugs used to sedate nursing home patients kills approximately 15,000 a year.  However there is evidence that off-label marketing is not as strong as it use to be.  Off-label use also means that prescription drugs may be used to alleviate other symptoms or conditions but not approved for use by the FDA.”  http://www.coreynahman.com/atypical-antipsychotic-lawsuits.html

 “Rosiglitazon (Avandia):   Approved by the FDA – A type 2 diabetes drug approved for diabetes 2 use in 1999 caused some patients to have heart attacks.   Rosiglitazon is an oral anti-diabetic drug that increases insensitivity to insulin.  After patients experienced, heart problems, liver failure, weight gain, low blood sugar and fractures the FDA put out a warning on the drug.  In 2005 the Canadian Medical Association Journal reported that Rosiglitazon caused partial blindness in 7 patients.  In 2007 a press release stated women that used Avandia showed increased signs of upper arm, feet and hand fractures.  In 2009, there is “no increase” in hospitalizations or death in comparison to those taking metformin with sulfonylurea.   But there were increases in heart failure and deaths for those taking Avandia.  The drug is still in use today and some patients are beginning to file lawsuits.”  http://www.avandia-injury-lawyer.com/index.php?gclid=CKbgwZyUr6QCFQsSbAodPibP0w

 “OFF-Label Plus,”

     It appears the drug industries are now focused on “Off-Label Plus” meaning to reduce or minimize false statements, or kickback incentives that would cause serious risk to patients.  In many cases some patients that have no other choice get treated with drugs that were originally intended and approved for a completely different use “without FDA approval!”

     The individual drug companies run these off-label research programs in a research setting funded by our government and “more than it should!”  This creates quite a lengthy mess during off-label prosecutions.  Research programs are causing our government to pay for more uses of drugs than it should through numerous individual Medicaid State agencies.  This off-label product-to-market channel is creating a complicated medical lawsuit nightmare for all parties involved.

     There are literally multiple-billion dollar; multi-national Companies with millions of “Off-Label Plus” claims throughout our nation.  In lawsuits, a heavy emphasis in the decision making process appears to be “patient harm versus patient benefit.”  Another major consideration in lawsuit cases is if research and development centers, physicians and/or sales reps have mislead the public trust, or the FDA in any serious way.  While in many other cases, if the off-label process were to be put to a halt, many patients may lose their life, while at the same time many lives may be saved. http://www.policymed.com/2010/07/pharmaceutical-marketing-lawsuits-slowing-considerably.html

Recommendation:  If you are taking any prescription drugs, and especially if that drug is one of the 41 class action lawsuits drugs found at the link I’ve provided above…  Learn all you can about the drug(s) and lawsuits, talk to your doctor and determine if there are better alternatives out there.  All too often, many of us tend to continue taking the same drugs for many years without physician follow up consultation to determine if health risk outweighs the benefits of using any particular, or combination of pharmaceuticals (annual physician consultations are a “good” ideal).  And through time, health condition, prescription formulation, dosages, may require prescription change; reducing risk while increasing health benefits. 

 Moderation and medical self-advocacy and due diligence is key in optimizing health benefits while reducing health risk.  This is especially true if you consume “any” product altered, or manufactured by man! 

 Author:  Marc T. Woodard, MBA, BS Exercise Science, USA Medical Services Officer, CPT, RET.  2010 Copyright, All rights reserved.  Mirror Athlete Enterprises Publishing @: www.mirrorathlete.com, Sign up for your free eNewsletter.